The MarketWatch News Department was not involved in the creation of this content.
Sep 15, 2020 (AmericaNewsHour) —
Global Theranostics Market Research Report: Information by Therapeutic Area (Oncology, Cardiovascular Diseases, Neurological Disorders, Immunological Disorders and others), Technology [Polymerase Chain Reaction (PCR), Immunohistochemistry (IHC), In Situ Hybridization (ISH), Sequencing, Others], End User (Hospitals and Clinics, Diagnostic Laboratories, Others) and Region – Forecast till 2025
Global theranostics market is expected to register a healthy CAGR over the forecast period. The theranostics market size accounted for USD 7,968.4 million in 2018 and is projected to grow at a CAGR of 11.4% during the forecast period. Theranostics is referred to as the combination of therapeutics, nanoscience, and diagnostics that provides a transition from conventional medicine to a contemporary personalized and precision medicine approach. Theranostics is also called as theragnostics or companion diagnostics (CDx), or pharmacodiagnostics or personalized medical care, or personalized therapy, or personalized